Prolapse Surgery: What Kind of Antibiotic Prophylaxis Is Necessary?

Area of Science:

• Urogynecology
• Surgical Infectious Diseases

Background:

• Pelvic organ prolapse surgery frequently utilizes mesh prostheses.
• Antibiotic use in mesh-related surgeries requires evaluation for optimal patient outcomes.

Purpose of the Study:

• To determine if antibiotic prophylaxis or therapy is adequate for laparoscopic or vaginal prolapse surgery using mesh.
• To compare the efficacy of different antibiotic regimens in preventing postoperative complications.

Main Methods:

• A single-center prospective study involving 87 patients undergoing prolapse surgery with mesh.
• Three antibiotic protocols were compared: Protocol A (metronidazole, piperacillin-tazobactam, and gentamicin), Protocol B (gentamicin and piperacillin-tazobactam), and Protocol C (clindamycin and gentamicin).
• Antibiotics were administered preoperatively, with some extended postoperatively in Protocol A.

Main Results:

• No significant differences in postoperative complications were observed across the three protocols.
• Urinary tract infections were more frequent in the vaginal approach compared to the laparoscopic route within Protocol A (p = 0.002).
• The study included 57 laparoscopic and 30 vaginal surgeries.

Conclusions:

• One-shot antibiotic prophylaxis is a viable and effective strategy for prolapse surgery involving mesh.
• The surgical approach (laparoscopic vs. vaginal) may influence the risk of specific complications like UTIs.
• Simplified antibiotic regimens can be safely employed in these procedures.